Results 111 to 120 of about 3,601 (193)

STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma. [PDF]

J Clin Oncol
Colman H, Lombardi G, Wong ET, Walbert T, Eoli M, Lassman AB, Peereboom DM, Kizilbash SH, Kamiya-Matsuoka C, Pitz MW, Strowd RE, Desjardins A, Kumthekar P, Mason W, Pellerino A, Soffietti R, Butowski N, Forsyth PA, Hamza MA, Hau P, Lallana E, Nabors B, Piccioni D, Uhlmann EJ, Welsh LC, Wen PY, Dietrich J, Wang C, Levin VA.   +28 more
europepmc   +1 more source

Combination of Intense Pulsed Light and Topical Eflornithine Therapy Versus Intense Pulsed Light Alone in the Treatment of Idiopathic Facial Hirsutism: A Randomized Controlled Trial. [PDF]

Cureus
Nawaz MU, Baig MB, Shahid SM, Nawaz MH, Inayat S, Dawood M.   +5 more
europepmc   +1 more source

Eflornithine for the Chemoprevention of Luminal Gastrointestinal Neoplasms: A Systematic Review. [PDF]

Gastroenterology Res
Godoy A, Montalvan-Sanchez D, Principe-Meneses FS, Riva-Moscoso A, Sierra L, Erazo G, Avila C, Ramirez-Rojas M, Giron R, Guifarro DA.   +9 more
europepmc   +1 more source

Use of fexinidazole in gambiense human African trypanosomiasis: a retrospective analysis of cases treated in Lui Hospital, South Sudan (2018-2024). [PDF]

Infection
Mariotti F, Paggi R, Basilico M, Pettenuzzo S, Benson GS, Amodu A, Zammarchi L, Rusconi S, Scanagatta C, Putoto G, Dacquino S, Gelormino E.   +11 more
europepmc   +1 more source

Chemoprevention in hereditary digestive neoplasia: A comprehensive review. [PDF]

Ther Adv Gastroenterol, 2023
Chevalier E, Benamouzig R.
europepmc   +1 more source

A CRISPR-based diagnostic tool to survey drug resistance in human African trypanosomiasis. [PDF]

Antimicrob Agents Chemother
Pérez Antón E, Dujeancourt-Henry A, Rotureau B, Glover L.   +3 more
europepmc   +1 more source

Transforming the chemotherapy of human African trypanosomiasis. [PDF]

Clin Microbiol Rev
Barrett MP.
europepmc   +1 more source

Antileishmanial and Antitrypanosomes Drugs for the Current Century. [PDF]

Microorganisms, 2023
Alunda JM.
europepmc   +1 more source

A network-driven computational framework for identifying FDA-approved drug repurposing across heterogeneous brain cancers. [PDF]

Front Mol Biosci
Prakash O.
europepmc   +1 more source

Eflornithine Hydrochloride [PDF]

, 2020
openaire   +1 more source